Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.1B | 10.6B | 10.3B | 11.0B |
Cost of revenue | 8.8B | 9.1B | 8.8B | 9.5B |
Gross profit | 1.2B | 1.6B | 1.5B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 539M | 535M | 487M | 523M |
Other operating expenses | — | — | — | — |
Operating income | 308M | 616M | 553M | 540M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 50M | 150M | 54M | 54M |
Other income expense | -33M | -183M | 201M | -59M |
Pretax income | 225M | 381M | 700M | 427M |
Tax provision | 72M | 147M | 192M | 99M |
Net income | 153M | 234M | 508M | 328M |
Basic EPS | — | 0.7 | 1.7 | 1.1 |
Diluted EPS | — | 0.7 | 1.7 | 1.1 |
Basic average shares | — | 204.5M | 205.5M | 205.5M |
Diluted average shares | — | 204.5M | 205.5M | 205.5M |
EBITDA | 723M | 1.7B | 978M | 950M |
Net income from continuing op. | 153M | 234M | 508M | 328M |
Minority interests | -7M | -31M | -24M | -15M |
Preferred stock dividends | — | — | — | — |